# Second Line Endovascular Treatment in Acute DVT

Study · id `cardio:ct-nct06486181` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06486181](<https://clinicaltrials.gov/study/NCT06486181>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06486181

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT06486181. Randomized; no masking; primary purpose treatment. Start 2026-04-01 (anticipated); primary completion 2028-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT06486181, source copy `cardio:ctgov-nct06486181-2026-01-28`, retrieved 2026-10-31)
- Planned start: 2026-04-01 (anticipated) (ClinicalTrials.gov record NCT06486181, source copy `cardio:ctgov-nct06486181-2026-01-28`, retrieved 2026-10-31)
- Primary completion: 2028-04-30 (anticipated) (ClinicalTrials.gov record NCT06486181, source copy `cardio:ctgov-nct06486181-2026-01-28`, retrieved 2026-10-31)
- Completion: 2029-04-30 (anticipated) (ClinicalTrials.gov record NCT06486181, source copy `cardio:ctgov-nct06486181-2026-01-28`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT06486181, source copy `cardio:ctgov-nct06486181-2026-01-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06486181-2026-01-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: Second Line Endovascular Treatment in Acute DVT
- Condition: Deep Venous Thrombosis
- Intervention (Other): Thrombolysis/Thrombectomy
- Lead sponsor: Rush University Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry lists this organization as the lead sponsor: Rush University Medical Center (`cardio:org-rush-university-medical-center`)

## Provenance

Content hash: f6c697c64b146a177f2a43c790a15face761b31a6114eca1d804c1011f3bbda3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
